A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience-Reference-Cited by-同舟云学术

A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience

Published:2018-05-30 Issue:1 Volume:11 Page:
ISSN:1757-2215
Container-title:Journal of Ovarian Research
language:en
Short-container-title:J Ovarian Res

Author:

Ghisoni Eleonora,Katsaros Dionyssios,Maggiorotto Furio,Aglietta Massimo,Vaira Marco,De Simone Michele,Mittica Gloria,Giannone Gaia,Robella Manuela,Genta Sofia,Lucchino Fabiola,Marocco Francesco,Borella Fulvio,Valabrega Giorgio,Ponzone Riccardo

Funder

Università degli Studi di Torino

Fondazione del Piemonte per l’Oncologia

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynaecology,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13048-018-0415-y.pdf

Reference43 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.

2. Ledermann JA, et al. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi24–32.

3. Chi DS, et al. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol Oncol. 2009;114(1):26–31.

4. du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux pour les etudes des cancers de l'Ovaire (GINECO). Cancer. 2009;115(6):1234–44.

5. Chi DS, et al. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas. Gynecol Oncol. 2010;119(1):38–42.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the treatment effectiveness in patients with stage IIB–IIIB ovarian cancer;Kazan medical journal;2024-07-25

2. Prognostic significance of pretreatment clinical and laboratory features in patients with ovarian cancer receiving neoadjuvant chemotherapy;Oncology in Clinical Practice;2024-06-06

3. Significance of Pretreatment Hemoglobin-Albumin-Lymphocyte-Platelet Index for the Prediction of Suboptimal Surgery in Epithelial Ovarian Cancer;World Journal of Oncology;2024-04

4. Utility of CA-125 in interval surgery;Obstetrics & Gynecology International Journal;2024-04-01

5. Radical Oophorectomy for Advanced Ovarian Cancer: A Feasibility Study from Tertiary Care Cancer Centre in Eastern India;The Journal of Obstetrics and Gynecology of India;2024-03-19